136 related articles for article (PubMed ID: 377710)
1. Role of anti-donor B lymphocyte antibodies in definitive allograft rejection.
Soulillou JP; de Mouzon A; Peyrat MA; Guenel J
Transplant Proc; 1979 Mar; 11(1):770-5. PubMed ID: 377710
[No Abstract] [Full Text] [Related]
2. The development and specificity of anti-B-cell antibodies during humoral rejection of kidney allografts.
Hardy M; Suciu-Foca N; McKiernan T; Rohowsky C; Cianci J; Jacob J; Pierce J; Reemtsma K
Transplant Proc; 1979 Mar; 11(1):389-92. PubMed ID: 377661
[No Abstract] [Full Text] [Related]
3. Anti-B lymphocytotoxins in renal-allograft rejection.
Ettenger RB; Terasaki PI; Ting A; Malekzadeh MH; Pennisi AJ; Uittenbogaart C; Garrison R; Fine RN
N Engl J Med; 1976 Aug; 295(6):305-9. PubMed ID: 778617
[TBL] [Abstract][Full Text] [Related]
4. Preexistent anti-HLA-DR antibodies and kidney graft survival.
Sirchia G; Mercuriali F; Scalamogna M; Rosso di San Secondo V; Pizzi C; Poli F; Fortis C; Greppi N
Transplant Proc; 1979 Mar; 11(1):950-3. PubMed ID: 377727
[No Abstract] [Full Text] [Related]
5. [The role of humoral antibodies in the rejection of a kidney allograft (a review of the literature)].
Drannik GN; Driianskaia VE
Vrach Delo; 1990 May; (5):45-9. PubMed ID: 2204199
[No Abstract] [Full Text] [Related]
6. B-lymphocyte-specific antibodies in human renal allografts.
Mohanakumar T; Giedlin M; DuVall C; Rhodes C; Phibbs M; Mendez G; Kaplan AM; Lee HM
Transplant Proc; 1979 Mar; 11(1):397-400. PubMed ID: 377664
[No Abstract] [Full Text] [Related]
7. Studies of the antibodies against HLA, Ia-like, Fc, and/or C3 receptors present in pretransplant sera: anti-B-cell antibodies not associated with accelerated graft loss.
Soulillou JP; Peyrat MA; Guenel J
Transplant Proc; 1978 Jun; 10(2):475-7. PubMed ID: 354139
[No Abstract] [Full Text] [Related]
8. Anti-donor's B lymphocytes and anti-IgG antibodies in kidney allograft recipients: correlative study with the transplant outcome.
de Mouzon A; Soulillou JP; Blanc M; Durand D; Ohayon E; Ducos J
Transplant Proc; 1979 Jun; 11(2):1267-8. PubMed ID: 382504
[No Abstract] [Full Text] [Related]
9. Positive cross-match for B-lymphocyte antigens (IA like) and kidney allograft behaviour.
Soulillou JP; Guenel J; Peyrat MA
Biomedicine; 1977 Jul; 27(5):183-4. PubMed ID: 336109
[TBL] [Abstract][Full Text] [Related]
10. HLA-D antigen disparity and HLA-DRw antibodies in intrafamilial renal allograft survival.
Cochrum K; Hanes D; Van Speybroeck J; Perkins H; Ferrone S; Indeveri F; Amend W; Vincenti F; Feduska N; Salvatierra O
Transplant Proc; 1979 Mar; 11(1):404-10. PubMed ID: 156426
[No Abstract] [Full Text] [Related]
11. MLC inhibitory alloantibodies and outcome of kidney allografts.
Suciu-Foca N; Hardy M; Kiamar M; Weiner J; Susinno E; Molinaro AP; Jacob J; Reemtsma K
Transplant Proc; 1978 Jun; 10(2):493-5. PubMed ID: 150083
[No Abstract] [Full Text] [Related]
12. Role of immunoglobulin (Ig)-G and IgM antibodies against donor human leukocyte antigens in organ transplant recipients.
Stastny P; Ring S; Lu C; Arenas J; Han M; Lavingia B
Hum Immunol; 2009 Aug; 70(8):600-4. PubMed ID: 19375468
[TBL] [Abstract][Full Text] [Related]
13. The role of renal endothelial antigens and donor-specific antibodies in allograft rejection.
Evans PR; Trickett LP; Smith JL; MacIver AG; Tate D; Slapak M
Transplant Proc; 1984 Oct; 16(5):1181. PubMed ID: 6385373
[No Abstract] [Full Text] [Related]
14. Clinical and anti-HLA antibody profile of nine renal transplant recipients with failed grafts: donor-specific and non-donor-specific antibody development.
Rebellato LM; Ozawa M; Verbanac KM; Catrou P; Haisch CE; Terasaki PI
Clin Transpl; 2006; ():241-53. PubMed ID: 18365382
[TBL] [Abstract][Full Text] [Related]
15. Characterization of B-cell and monocyte antibodies in recipient sera and in eluates from rejected kidney allografts.
Nunez G; McPhaul J; Stastny P
Transplant Proc; 1981 Mar; 13(1 Pt 1):111-3. PubMed ID: 7022807
[TBL] [Abstract][Full Text] [Related]
16. Abrogation of anti-HLA antibodies via proteasome inhibition.
Trivedi HL; Terasaki PI; Feroz A; Everly MJ; Vanikar AV; Shankar V; Trivedi VB; Kaneku H; Idica AK; Modi PR; Khemchandani SI; Dave SD
Transplantation; 2009 May; 87(10):1555-61. PubMed ID: 19461494
[TBL] [Abstract][Full Text] [Related]
17. Humoral immunity in renal transplantation Detection of cytotoxic antibodies to lymphocyte antigens other than HLA-A,B,C and Ia-like antigens in patients with vascular graft rejection.
Lordon RE; Wilson RL; Shield CF; Ferrone S
Transplantation; 1981 Oct; 32(4):286-90. PubMed ID: 7036445
[TBL] [Abstract][Full Text] [Related]
18. Antibody-mediated rejection: treatment alternatives and outcomes.
Singh N; Pirsch J; Samaniego M
Transplant Rev (Orlando); 2009 Jan; 23(1):34-46. PubMed ID: 19027615
[TBL] [Abstract][Full Text] [Related]
19. Donor-specific antibodies against HLA, MICA, and GSTT1 in patients with allograft rejection and C4d deposition in renal biopsies.
Alvarez-Márquez A; Aguilera I; Gentil MA; Caro JL; Bernal G; Fernández Alonso J; Acevedo MJ; Cabello V; Wichmann I; Gonzalez-Escribano MF; Núñez-Roldán A
Transplantation; 2009 Jan; 87(1):94-9. PubMed ID: 19136897
[TBL] [Abstract][Full Text] [Related]
20. Association between treatment-resistant kidney-allograft rejection and post-transplant appearance of antibodies to donor B-lymphocyte alloantigens.
Soulillou JP; Peyrat MA; Guenel J
Lancet; 1978 Feb; 1(8060):354-6. PubMed ID: 75395
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
